![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/affiris-and-frontier-biotechnologies-announce-license-agreement-for-affitopeat04-an-active-immunotherapy-targeting-pcsk9-to-treat-hypercholesterolemia-in-greater-china-1642055496.pdf
https://www.pharmacompass.com/pdf/news/affiris-positive-phase-1-results-with-immunotherapies-targeting-pcsk9-1624535329.pdf
https://www.pharmacompass.com/pdf/news/positive-preclinical-in-vivo-results-with-affiris-antibody-mab-c6-17-1622609789.pdf
https://finance.yahoo.com/news/affiris-announces-fda-response-pre-093000849.html